Dextran Formulations as Effective Delivery Systems of Therapeutic Agents
Molecules · 21.01.2023 · 28 (3) · 1086
DOI: 10.3390/molecules28031086 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 21.01.2023. Verfasst von Anca Roxana Petrovici und 2 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Advanced Research in Bionanoconjugates and Biopolymers, "Petru Poni" Institute of Macromolecular Chemistry, 41A Grigore Ghica Voda Alley, 7…. Hauptthemen laut MEDLINE: Dextrans, Nanoparticles. Die Arbeit wurde bisher 131-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Research, Innovation and Digitization, CCCDI - UEFISCDI, Ministry of Research, Innovation and Digitization, CCCDI—UEFISCDI.
Abstract (Originalsprache)
Dextran is by far one of the most interesting non-toxic, bio-compatible macromolecules, an exopolysaccharide biosynthesized by lactic acid bacteria. It has been extensively used as a major component in many types of drug-delivery systems (DDS), which can be submitted to the next in-vivo testing stages, and may be proposed for clinical trials or pharmaceutical use approval. An important aspect to consider in order to maintain high DDS’ biocompatibility is the use of dextran obtained by fermentation processes and with a minimum chemical modification degree. By performing chemical modifications, artefacts can appear in the dextran spatial structure that can lead to decreased biocompatibility or even cytotoxicity. The present review aims to systematize DDS depending on the dextran type used and the biologically active compounds transported, in order to obtain desired therapeutic effects. So far, pure dextran and modified dextran such as acetalated, oxidised, carboxymethyl, diethylaminoethyl-dextran and dextran sulphate sodium, were used to develop several DDSs: microspheres, microparticles, nanoparticles, nanodroplets, liposomes, micelles and nanomicelles, hydrogels, films, nanowires, bio-conjugates, medical adhesives and others. The DDS are critically presented by structures, biocompatibility, drugs loaded and therapeutic points of view in order to highlight future therapeutic perspectives.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre of Advanced Research in Bionanoconjugates and Biopolymers, "Petru Poni" Institute of Macromolecular Chemistry, 41A Grigore Ghica Voda Alley, 700487 Iasi, Romania.
- The Research Institute of the University of Bucharest (ICUB), 90 Sos. Panduri, 050663 Bucharest, Romania.
ORCID-Profile: Anca Roxana Petrovici, Mariana Pinteala, Natalia Simionescu
Förderung
- Ministry of Research, Innovation and Digitization, CCCDI - UEFISCDI
- Ministry of Research, Innovation and Digitization, CCCDI—UEFISCDI
Zitieren
APA
Petrovici, A. R., Pinteala, M., & Simionescu, N. (2023). Dextran Formulations as Effective Delivery Systems of Therapeutic Agents. Molecules, 28(3), 1086. https://doi.org/10.3390/molecules28031086
Vancouver
Petrovici AR, Pinteala M, Simionescu N. Dextran Formulations as Effective Delivery Systems of Therapeutic Agents. Molecules. 2023;28(3):1086. doi:10.3390/molecules28031086
BibTeX
@article{Petrovici2023,
author = {Petrovici, Anca Roxana and Pinteala, Mariana and Simionescu, Natalia},
title = {Dextran Formulations as Effective Delivery Systems of Therapeutic Agents},
journal = {Molecules},
year = {2023},
volume = {28},
number = {3},
pages = {1086},
doi = {10.3390/molecules28031086}
}
EUVIMED